Last update:

Medications news

Medications

Antibiotic treatment for drug-resistant tuberculosis found to be safe and effective in clinical trial

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug-resistant tuberculosis (TB), ...

Medications

Semaglutide can also be beneficial to people with type 1 diabetes, clinical trial finds

Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited data on its risks and benefits ...

Medications

What to do if you miss a dose of GLP-1

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug—better known as GLP-1—for weight loss, the protocol for getting back on track may be different ...

Medications

Q&A: Why are antidepressants underprescribed?

The University of Virginia's Dr. Anita Clayton has been a primary investigator for nearly every antidepressant approved in the United States since 1990.

Medications

Medicare rules may reduce prescription steering

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, ...

Medications

New drug for prostate cancer patients in clinical trials

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical ...

Medications

Talquetamab plus teclistamab shows promise in multiple myeloma

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 infections than with either therapy alone, according ...

Medications

Acetaminophen may be less heart-safe than previously thought

The common painkiller acetaminophen was found to alter proteins in the heart tissue when used regularly at moderate doses, according to a new study conducted in mice. Researchers presented their work at the American Physiology ...

Medications

Chelation therapy does not improve outcomes after heart attack

People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke ...

Medications

Plozasiran reduces triglyceride levels by 74% at 24 weeks

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...

Medications

US company withdraws ALS drug after it fails in trial

Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.